Paragon Care Ltd
PGC
Company Profile
Business description
Paragon Care Ltd is a medical device company. The company provides medical equipment, devices, and consumables medical products to the healthcare market. The company provides solutions to various healthcare markets, aged care, and veterinary markets. The group is organized into two operating segments: ParagonCare and CH2 Holdings and the majority of its revenues are generated from the CH2 Holdings segment engaged in the distribution of pharmaceuticals, medical consumables, nutritional, and over-the-counter products to the healthcare market.
Contact
77-97 Ricketts Road
Mount Waverley
MelbourneVIC3149
AUST: +61 388337800
Sector
Healthcare
Stock type
Defensive
Industry
Medical Distribution
Fiscal Year End
30 June 2026
Employees
508
Stocks News & Analysis
stocks
Avoid this overpriced ASX share
This ASX share is 84% overvalued and lacks a sustainable competitive advantage.
stocks
Markets brief: How will AI affect economic moats? Morningstar’s take on the new paradigm
A broad assessment of AI’s threats and opportunities leads to moat ratings changes for more than three dozen companies.
stocks
Baidu: Moat downgraded to none from wide; AI segment growth to offset search decline in long \run
We’ve also lowered our fair value estimate of Baidu stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,924.20 | 8.30 | -0.09% |
| CAC 40 | 8,089.26 | 173.90 | 2.20% |
| DAX 40 | 24,035.07 | 625.70 | 2.67% |
| Dow JONES (US) | 47,998.68 | 257.88 | 0.54% |
| FTSE 100 | 10,433.15 | 183.63 | 1.79% |
| HKSE | 25,959.90 | 551.44 | 2.17% |
| NASDAQ | 22,843.75 | 147.81 | 0.65% |
| Nikkei 225 | 54,248.39 | 1,519.67 | 2.88% |
| NZX 50 Index | 13,094.37 | 4.46 | -0.03% |
| S&P 500 | 6,824.06 | 28.07 | 0.41% |
| S&P/ASX 200 | 8,692.60 | 11.80 | -0.14% |
| SSE Composite Index | 4,123.14 | 26.54 | 0.65% |